Skip to main content
. 2015 Jan 7;4(3):e990773. doi: 10.4161/2162402X.2014.990773

Figure 5.

Figure 5.

Long-term dynamics of “natural” and CD16-dependent cytotoxic activities in peripheral blood of DLBCL patients. (A) “natural” (anti-K562) and (B) CD16-dependent (anti-P815 + anti-CD16 monoclonal antibody [mAb]) cytotoxic activities of peripheral blood mononuclear cells (PBMCs) of diffuse large B cell lymphoma (DLBCL) patients at different time points (T1-T6, gray boxes) and of healthy controls (HC, empty boxes); data are expressed in lytic units at 10% cytotoxicity/106 PBMC. Bars represent median and 10–90 percentile; dots represent outliers. ***P < 0.0001, ****P < 0.00005 vs. controls.